Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-10-31T17:19:51.830Z Has data issue: false hasContentIssue false

Genomic Epidemiology of Carbapenemase-Producing Enterobacterales (CPE) in Toronto, Canada

Published online by Cambridge University Press:  02 November 2020

Alainna Juliette Jamal
Affiliation:
University of Toronto
Victoria Williams
Affiliation:
Sunnybrook Health Sciences Centre
Jerome Leis
Affiliation:
University of Toronto
Nathalie Tijet
Affiliation:
Public Health Ontario Laboratory
Sandra Zittermann
Affiliation:
Public Health Ontario Laboratory
Roberto Melano
Affiliation:
Public Health Ontario Laboratory
Laura Mataseje
Affiliation:
National Microbiology Laboratory
Michael Mulvey
Affiliation:
National Microbiology Laboratory
Allison McGeer
Affiliation:
Mount Sinai Hospital
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Objective: We investigated whether whole-genome sequencing (WGS) data altered interpretations of clonal transmission as determined by conventional epidemiology and pulsed-field gel electrophoresis (PFGE) at a tertiary-care hospital (hospital Z, HZ). Methods: We included all carbapenemase-producing Enterobacterales (CPE)–colonized or –infected patients identified via population-based surveillance from 2007 through 2018, who were admitted to HZ during and/or in the year prior to or following CPE detection. HZ reported clonal transmission clusters using epidemiology and PFGE for CPE identified at HZ or reported to HZ by other hospitals as potentially acquired at HZ. We assessed single-nucleotide polymorphism (SNP) phylogenies and case epidemiology. Results: Overall, 85 CPE-colonized or -infected patients were included: 50 were detected at HZ and 35 were detected at another local hospital but were admitted to HZ in the previous or following year. HZ reported 6 transmission clusters (Table 1). SNP analyses confirmed clusters B, C, E, and F. In cluster A, SNP analyses cast doubt on 2 of 9 cases (possibly representing plasmid transmission) but also identified 2 additional cases with isolates highly related (0–3 SNP differences) to other isolates. One case may be the index case: a travel-related case who stayed on the same unit as case 1, 4 months before case 1 detection. The second case stayed in a room previously occupied by 5 cluster A cases. In cluster D, SNP analyses found 1 additional case whose isolate was highly related (ie, 17–19 SNP differences) to other isolates. This case was identified a year before cluster D at another hospital that shares patients with HZ; however, the case’s admission to HZ was after all cluster D cases were detected and no direct epidemiologic link was identified. Conclusions: WGS data can identify cases belonging to transmission clusters that conventional epidemiologic methods missed.

Funding: None

Disclosures: Allison McGeer reports funds to her institution from Pfizer and Merck for projects for which she is the principal investigator. She also reports consulting fees from Sanofi-Pasteur, Sunovion, GSK, Pfizer, and Cidara

Type
Poster Presentations
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.